167 related articles for article (PubMed ID: 37352528)
1. Neoadjuvant intensity modulated radiotherapy for a single and small (≤5 cm) hepatitis B virus-related hepatocellular carcinoma predicted to have high risks of microvascular invasion: a randomized clinical trial.
Wei X; Jiang Y; Feng S; Lu C; Huo L; Zhou B; Meng Y; Lau WY; Zheng Y; Cheng S
Int J Surg; 2023 Oct; 109(10):3052-3060. PubMed ID: 37352528
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial.
Wu F; Chen B; Dong D; Rong W; Wang H; Wang L; Wang S; Jin J; Song Y; Liu Y; Fang H; Tang Y; Li N; Zhu X; Li Y; Wang W; Wu J
JAMA Surg; 2022 Dec; 157(12):1089-1096. PubMed ID: 36197682
[TBL] [Abstract][Full Text] [Related]
3. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study.
Wei X; Jiang Y; Zhang X; Feng S; Zhou B; Ye X; Xing H; Xu Y; Shi J; Guo W; Zhou D; Zhang H; Sun H; Huang C; Lu C; Zheng Y; Meng Y; Huang B; Cong W; Lau WY; Cheng S
J Clin Oncol; 2019 Aug; 37(24):2141-2151. PubMed ID: 31283409
[TBL] [Abstract][Full Text] [Related]
5. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
[TBL] [Abstract][Full Text] [Related]
7. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
[TBL] [Abstract][Full Text] [Related]
8. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Estimated Risk of Microvascular Invasion is Associated with Prognostic Differences Following Liver Resection Versus Radiofrequency Ablation for Early Hepatitis B Virus-Related Hepatocellular Carcinoma.
Bai S; Yang P; Xie Z; Li J; Lei Z; Xia Y; Qian G; Zhang B; Pawlik TM; Lau WY; Shen F
Ann Surg Oncol; 2021 Dec; 28(13):8174-8185. PubMed ID: 34409542
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
[TBL] [Abstract][Full Text] [Related]
11. Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study.
Zhang XP; Chai ZT; Feng JK; Zhu HM; Zhang F; Hu YR; Zhong CQ; Chen ZH; Wang K; Shi J; Guo WX; Chen CS; Wu MC; Lau WY; Cheng SQ
Eur J Surg Oncol; 2022 Jan; 48(1):142-149. PubMed ID: 34452770
[TBL] [Abstract][Full Text] [Related]
12. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Shen A; Liu M; Zheng D; Chen Q; Wu Z
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
[TBL] [Abstract][Full Text] [Related]
14. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
Lin H; Li X; Liu Y; Hu Y
ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
[TBL] [Abstract][Full Text] [Related]
16. Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria.
Hou YF; Li B; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LV; Chen KF
Medicine (Baltimore); 2015 Dec; 94(48):e2070. PubMed ID: 26632890
[TBL] [Abstract][Full Text] [Related]
17. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels.
Wang WH; Wang Z; Wu JX; Zhang T; Rong WQ; Wang LM; Jin J; Wang SL; Song YW; Liu YP; Ren H; Fang H; Wang WQ; Liu XF; Yu ZH; Li YX
Liver Int; 2015 Dec; 35(12):2603-10. PubMed ID: 25939444
[TBL] [Abstract][Full Text] [Related]
19. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
Yang JF; Lo CH; Lee MS; Lin CS; Dai YH; Shen PC; Chao HL; Huang WY
Radiat Oncol; 2019 Oct; 14(1):180. PubMed ID: 31640728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]